MedTrace Logo

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

NCT05795062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13945

Last updated 2024-11-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess outpatient treatment patterns following hospitalization for venous thromboembolism (VTE). VTE is a condition that occurs when blood clot forms in the vein.

This is a retrospective study (assessments on events that have already occurred) of healthcare claims from databases. The study sponsors will assess healthcare claim records of patients treated with either apixaban or warfarin. Assessment includes treatment persistence, switch, and stopping therapy, along with recurrent VTE and bleeding.

Conditions

  • Venous Thromboembolism

Interventions

DRUG

apixaban

patients treated with apixaban

DRUG

warfarin

patients treated with warfarin

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05795062 on ClinicalTrials.gov